EE558 The Cost-Effectiveness of Budesonide/Formoterol Maintenance and Reliever Therapy Versus Salmeterol/Fluticasone Plus As-Needed Salbutamol Among Asthma Patients ≥12 Years in China
Dec 1, 2023, 00:00
10.1016/j.jval.2023.09.823
https://www.valueinhealthjournal.com/article/S1098-3015(23)03953-0/fulltext
Title :
EE558 The Cost-Effectiveness of Budesonide/Formoterol Maintenance and Reliever Therapy Versus Salmeterol/Fluticasone Plus As-Needed Salbutamol Among Asthma Patients ≥12 Years in China
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)03953-0&doi=10.1016/j.jval.2023.09.823
First page :
Section Title :
Open access? :
No
Section Order :
10317